Risk threshold for starting low dose aspirin in pregnancy to prevent preeclampsia: an opportunity at a low cost.
Preeclampsia (PE) increases maternal and perinatal morbidity and mortality. Based on a multitude of data from randomized clinical trials, clinical practice guidelines endorse using ASA to prevent PE in women who are "at risk." However, data are lacking about the level of absolute risk to w...
Main Authors: | Emily Bartsch, Alison L Park, John C Kingdom, Joel G Ray |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4366221?pdf=render |
Similar Items
-
Low-dose aspirin in the prevention of preeclampsia in twin pregnancies: A real-world study
by: Qiongjie Zhou, et al.
Published: (2023-01-01) -
The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta
by: Scott W. Walsh, et al.
Published: (2021-06-01) -
Prevention of preeclampsia using low dose Aspirin: A randomised controlled trial
by: Aseel Mosa Jabber
Published: (2019-04-01) -
Prevention of preeclampsia using low dose Aspirin: A randomised controlled trial
by: Aseel Mosa Jabber
Published: (2019-04-01) -
Prevention of preeclampsia using low dose Aspirin: A randomised controlled trial
by: Aseel Mosa Jabber
Published: (2019-04-01)